Meroni Roberta, Gianni Stefano, Guarnieri Marcello, Saglietti Francesco, Gemma Marco, Zangrillo Alberto, Bignami Elena
Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.
J Cardiothorac Vasc Anesth. 2017 Aug;31(4):1210-1217. doi: 10.1053/j.jvca.2016.12.018. Epub 2016 Dec 18.
Adequate maintenance of hypnosis during anesthesia throughout surgery using sevoflurane alone was investigated. In addition, sevoflurane pharmacokinetics during cardiopulmonary bypass were analyzed.
This was a pilot pharmacokinetic study.
Tertiary care university hospital.
The study comprised 10 patients aged between 18 and 75 years who underwent elective mitral valve surgery.
The end-tidal and sevoflurane plasma concentrations were measured throughout cardiac surgery procedures involving cardiopulmonary bypass. The sevoflurane plasma concentration was measured using gas chromatography. In addition, the ratio between sevoflurane alveolar concentration and inspired concentration over time (F/F) was analyzed to describe wash-in and wash-out curves.
Hypnosis was maintained adequately throughout surgery using sevoflurane alone. The bispectral index was maintained between 40 and 60 during cardiopulmonary bypass. The end-tidal sevoflurane was significantly different before and during cardiopulmonary bypass (1.86%±0.54% v 1.30%±0.58%, respectively; p<0.001). However, the sevoflurane plasma concentration was not significantly different before and after cardiopulmonary bypass start-up (40.55 µg/mL [76.62-125.33] before cardiopulmonary bypass and 36.24 µg/mL [56.49-81-42] during cardiopulmonary bypass). This mismatch possibly can be explained by changes that occured after cardiopulmonary bypass start-up, such as reductions of body temperature (36.33°C±0.46°C v 32.98°C±2.38°C, respectively; p<0.001) and hematocrit (35.62%±3.98% v 25.5%±3.08%, respectively; p<0.001). The sevoflurane alveolar concentration varied according to sevoflurane plasma concentration and bispectral index values. No adverse events regarding sevoflurane administration during cardiopulmonary bypass were observed.
Sevoflurane end-tidal values were reliable indicators of adequate anesthesia during all cardiac surgery procedures involving cardiopulmonary bypass.
研究仅使用七氟醚在整个手术麻醉过程中维持适当催眠状态的情况。此外,分析了体外循环期间七氟醚的药代动力学。
这是一项初步药代动力学研究。
三级护理大学医院。
该研究包括10名年龄在18至75岁之间接受择期二尖瓣手术的患者。
在涉及体外循环的心脏手术过程中,全程测量呼气末和血浆七氟醚浓度。使用气相色谱法测量血浆七氟醚浓度。此外,分析七氟醚肺泡浓度与吸入浓度随时间的比值(F/F)以描述吸入和呼出曲线。
仅使用七氟醚在整个手术过程中维持了适当的催眠状态。在体外循环期间,脑电双频指数维持在40至60之间。体外循环前和期间呼气末七氟醚浓度有显著差异(分别为1.86%±0.54%和1.30%±0.58%;p<0.001)。然而,体外循环启动前后血浆七氟醚浓度无显著差异(体外循环前为40.55μg/mL[76.62 - 125.33],体外循环期间为36.24μg/mL[56.49 - 81.42])。这种不匹配可能是由于体外循环启动后发生的变化,如体温降低(分别为36.33°C±0.46°C和32.98°C±2.38°C;p<0.001)和血细胞比容降低(分别为35.62%±3.98%和25.5%±3.08%;p<0.001)。七氟醚肺泡浓度随血浆七氟醚浓度和脑电双频指数值而变化。在体外循环期间未观察到与七氟醚给药相关的不良事件。
在所有涉及体外循环的心脏手术过程中,呼气末七氟醚值是充分麻醉的可靠指标。